Turning Point Therapeutics (TPTX) Short Interest Ratio & Short Volume → This company has increased its dividend every year for 54 years (From DTI) (Ad) Free TPTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Turning Point Therapeutics Short Interest DataCurrent Short Volume2,140,000 sharesPrevious Short Volume2,130,000 sharesChange Vs. Previous Month+0.47%Dollar Volume Sold Short$160.46 millionShort Interest Ratio / Days to Cover1.2Last Record DateJuly 31, 2022Outstanding Shares50,074,000 sharesFloat Size42,680,000 sharesShort Percent of Float5.01%Today's Trading Volume4,322 sharesAverage Trading Volume1,137,726 sharesToday's Volume Vs. Average0% Short Selling Turning Point Therapeutics ? Sign up to receive the latest short interest report for Turning Point Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTPTX Short Interest Over TimeTPTX Days to Cover Over TimeTPTX Percentage of Float Shorted Over Time Ad DTIStart loving Mondays like thisWouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!Weekend after weekend! Turning Point Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20222,140,000 shares $160.46 million +0.5%5.0%1.2 $74.98 7/15/20222,130,000 shares $159.00 million -25.5%5.0%1.2 $74.65 6/30/20222,860,000 shares $215.22 million -5.3%6.7%1.5 $75.25 6/15/20223,020,000 shares $226.20 million -26.2%7.1%1.8 $74.90 5/31/20224,090,000 shares $144.66 million -0.5%9.6%3 $35.37 5/15/20224,110,000 shares $133.99 million +15.1%9.6%6.3 $32.60 Get the Latest News and Ratings for TPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Turning Point Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/30/20223,570,000 shares $105.10 million +10.9%8.3%5.8 $29.44 4/15/20223,220,000 shares $105.94 million +3.9%7.5%5.5 $32.90 3/31/20223,100,000 shares $83.24 million -1.0%N/A6.2 $26.85 3/15/20223,130,000 shares $78.59 million +4.7%N/A6.1 $25.11 2/28/20222,990,000 shares $94.66 million +22.5%6.9%5.9 $31.66 2/15/20222,440,000 shares $87.82 million +22.6%5.7%4.9 $35.99 1/31/20221,990,000 shares $74.09 million -4.3%4.7%4.1 $37.23 1/15/20222,080,000 shares $79.75 million -5.9%4.9%4.5 $38.34 12/31/20212,210,000 shares $105.42 million +8.9%5.2%4.6 $47.70 12/15/20212,030,000 shares $82.99 million -6.9%4.7%3.8 $40.88 11/30/20212,180,000 shares $82.97 million +1.4%5.1%4.6 $38.06 11/15/20212,150,000 shares $96.11 million -22.9%5.0%4.9 $44.70 10/29/20212,790,000 shares $116.01 million +20.3%6.5%6.7 $41.58 10/15/20212,320,000 shares $108.65 million +2.2%5.4%5.5 $46.83 9/30/20212,270,000 shares $150.80 million -4.2%5.3%5.9 $66.43 9/15/20212,370,000 shares $184.88 million -6.7%5.5%6.4 $78.01 8/31/20212,540,000 shares $195.63 million -2.7%5.9%6 $77.02 8/13/20212,610,000 shares $173.17 million -1.9%6.1%5.8 $66.35 7/30/20212,660,000 shares $169.76 million -2.9%6.2%5.6 $63.82 7/15/20212,740,000 shares $184.81 million -14.4%6.1%5.4 $67.45 6/30/20213,200,000 shares $249.66 million +9.6%7.1%6 $78.02 6/15/20212,920,000 shares $227.73 million +5.0%6.5%5.9 $77.99 5/28/20212,780,000 shares $183.98 million +4.9%6.2%6 $66.18 5/14/20212,650,000 shares $180.94 million -2.9%N/A6 $68.28 4/30/20212,730,000 shares $212.83 million -2.9%N/A6.5 $77.96 4/15/20212,810,000 shares $213.28 million +17.6%N/A7.5 $75.90 3/31/20212,390,000 shares $213.91 million +4.4%N/A7.1 $89.50 3/15/20212,290,000 shares $262.43 million +8.5%N/A7.7 $114.60 2/26/20212,110,000 shares $246.68 million +7.1%N/A7.3 $116.91 2/12/20211,970,000 shares $265.22 million No ChangeN/A7 $134.63 1/29/20211,970,000 shares $237.74 million -5.3%N/A6.6 $120.68 1/15/20212,080,000 shares $284.94 million -5.5%N/A5.5 $136.99 12/31/20202,200,000 shares $274.16 million -10.2%N/A5.4 $124.62 12/15/20202,450,000 shares $309.78 million -7.9%N/A5.8 $126.44Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic TPTX Short Interest - Frequently Asked Questions What is Turning Point Therapeutics' current short interest? Short interest is the volume of Turning Point Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 2,140,000 shares of TPTX short. 5.01% of Turning Point Therapeutics' shares are currently sold short. Learn More on Turning Point Therapeutics' current short interest. What is a good short interest ratio for Turning Point Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TPTX shares currently have a short interest ratio of 1.0. Learn More on Turning Point Therapeutics's short interest ratio. What is a good short interest percentage for Turning Point Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.01% of Turning Point Therapeutics' floating shares are currently sold short. Is Turning Point Therapeutics' short interest increasing or decreasing? Turning Point Therapeutics saw a increase in short interest in July. As of July 31st, there was short interest totaling 2,140,000 shares, an increase of 0.5% from the previous total of 2,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Turning Point Therapeutics' float size? Turning Point Therapeutics currently has issued a total of 50,074,000 shares. Some of Turning Point Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Turning Point Therapeutics currently has a public float of 42,680,000 shares. How does Turning Point Therapeutics' short interest compare to its competitors? 5.01% of Turning Point Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Turning Point Therapeutics: CymaBay Therapeutics, Inc. (5.10%), Insmed Incorporated (6.09%), Ultragenyx Pharmaceutical Inc. (4.76%), Axsome Therapeutics, Inc. (16.15%), Prestige Consumer Healthcare Inc. (3.52%), Amicus Therapeutics, Inc. (11.00%), Bausch Health Companies Inc. (6.31%), Biohaven Ltd. (10.50%), Crinetics Pharmaceuticals, Inc. (7.05%), Arrowhead Pharmaceuticals, Inc. (7.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: KLA Co. ($2.87 billion), Lucid Group, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.08 billion), Coinbase Global, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.85 billion), Chesapeake Energy Co. ($1.81 billion), Rivian Automotive, Inc. ($1.64 billion), Lumen Technologies, Inc. ($1.61 billion), Plug Power Inc. ($1.50 billion), and Generac Holdings Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Turning Point Therapeutics stock? Short selling TPTX is an investing strategy that aims to generate trading profit from Turning Point Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Turning Point Therapeutics? A short squeeze for Turning Point Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TPTX, which in turn drives the price of the stock up even further. How often is Turning Point Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TPTX, twice per month. The most recent reporting period available is July, 31 2022. More Short Interest Resources from MarketBeat Related Companies: CBAY Short Interest Data INSM Short Interest Data RARE Short Interest Data AXSM Short Interest Data PBH Short Interest Data FOLD Short Interest Data BHC Short Interest Data BHVN Short Interest Data CRNX Short Interest Data ARWR Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TPTX) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative